Samuel Rosner, M.D.

NPI 1114450871ActiveIndividual· Internal Medicine, Medical Oncology· Baltimore, MD

Internal Medicine, Medical Oncology (M.D.) in Baltimore, Maryland, trained at Albert Einstein College of Medicine of Yeshiva University (class of 2017). Their prescriptions cost Medicare Part D more than their services did: $302,630 for 190 claims, against $30,275 paid for services in 2024. Astrazeneca Pharmaceuticals LP was the largest of 4 companies reporting payments in 2025, $7,908 in all, mostly consulting fees.

Overview

NPI	1114450871
Status	Active
Entity type	Individual
Credential	M.D.
Sole proprietor	No
NPI issued	Apr 9, 2017
Last updated in NPPES	Oct 24, 2023
Certified by provider	Oct 24, 2023

Specialties and licenses

Taxonomy	Code	License	State
Internal Medicine, Medical Oncology Primary	207RX0202X	D0092604	MD

About license numbers in NPPES

Exclusion screening

List	Result	Details
HHS-OIG LEIE · Nov 10, 2026	No match	Checked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026	No match	—
New York OMIG · Nov 11, 2026	No match	—
Ohio Medicaid · Nov 11, 2026	No match	—
Pennsylvania Medicheck · Nov 11, 2026	No match	—
Washington HCA · Nov 11, 2026	No match	—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)	Enrolled Practitioner - Internal Medicine (MD)
Accepts assignment	Yes (participating)

Medicare services in 2024

Medicare patients	84
Services billed	343 across 10 procedure codes
Paid by Medicare	$30,275

Part D prescriptions in 2024

Prescriptions (claims)	190 · 219 30-day fills
Patients	28
Total drug cost	$302,630
Generic share	81% of claims

Medicare sources and data years

Education and affiliations

Medical school	Albert Einstein College of Medicine of Yeshiva University
Graduation year	2017
Medicare specialty	Internal Medicine
Secondary specialties	Medical Oncology
Telehealth	Offers telehealth